Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Frailty model with change points for survival analysis37
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long‐term endpoint: The non‐Gaussian case24
Improved inference forMCP‐Modapproach using time‐to‐event endpoints with small sample sizes18
Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real‐World Setting18
A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials18
Pre‐Posterior Distributions in Drug Development and Their Properties18
A Likelihood Perspective on Dose‐Finding Study Designs in Oncology17
Average Hazard as Harmonic Mean16
15
Estimators for handling COVID‐19‐related intercurrent events with a hypothetical strategy15
Weighted log‐rank test to compare two survival functions in the presence of dependent censoring14
Information‐based group sequential design for post‐market safety monitoring of medical products using real world data13
A conservative approach to leveraging external evidence for effective clinical trial design13
Applying the Estimand Framework to Non‐Inferiority Trials13
A meta‐analytic framework to adjust for bias in external control studies13
0.15849995613098